Closed System Corrosion Inhibitor Tablet
Price
Name
WTP CWS 296T
Description
WTP CWS 296T is a very effective tablet corrosion inhibitor for chilled water systems, closed loop cooling systems and hot water heating systems.
WTP CWS 296T contains;
- Sodium Molybdate
- Organic inhibitors
- pH Buffers
- Copper corrosion inhibitor
Advantages
- Excellent corrosion inhibiting properties.
- Easy to apply.
- Improved Handling and transport over liquids.
- Reduces risk of splash, spills and environmental exposure.
- Neutral pH range for systems containing Aluminum.
- Provides economical waterside protection for mixed metal systems containing copper, brass and ferrous based metals.
Specification
| Physical State | Hard tablet |
| Weight | 20g +/-5% |
| Colour | Off white |
| Diameter> | 30.0mm |
| Depth | 18.5mm |
Dosing
- Tablets are added to the closed system via a suitable dosing pot.
- Dosing pots offer a simple low maintenance method of accurately adding tablets.
- Add 50 X 20g WTP CWS 296T per cubic metre of water in system. (0.1% system volume).
- A Molybdate test kit (WTP TK160) is available for testing and control of WTP CWS 296T, recommended concentration level is 80-120 ppm of Molybdate (as MoO4).
Handling
Please refer to material safety data sheet for detailed handling/storage instructions
Application
Packaging
WTP CWS 296T treatments are shipped as 1 kg (50 x 20g) per pot or 5kg (250 x 20g) per pail.
Service
Field Representatives will work closely with customer personnel to assure the effective application of the water treatment programme. Regular service calls can be provided by qualified personnel.
More Information
To enquire further about this product click here
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The company shall not be held liable for any damage resulting from handling, contact, mis-use or mis-application of the above product. In all instances the user should satisfy themselves that this product is suitable for the anticipated application and should carry out suitable and sufficient risk/COSHH assessments and a method of use statement.
